Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis

Details for Australian Patent Application No. 2006286563 (hide)

Owner Actogenix NV Ablynx N.V.

Inventors Rottiers, Pieter; Vandenbroucke, Klaas

Agent Shelston IP

Pub. Number AU-B-2006286563

PCT Pub. Number WO2007/025977

Priority 05111654.9 02.12.05 EP; 05107909.3 30.08.05 EP

Filing date 30 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 23 February 2012

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 36/06 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines - Fungi, e.g. yeasts

A61K 36/064 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C12N 1/12 (2006.01) Micro-organisms, e.g. protozoa - Unicellular algae

C12N 1/16 (2006.01) Micro-organisms, e.g. protozoa - Yeasts

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12N 15/81 (2006.01) Mutation or genetic engineering - for yeasts

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/025977 Priority application(s): WO2007/025977

11 December 2008 Alteration of Name

  The name of the applicant has been altered to Ablynx N.V.; Actogenix NV

23 February 2012 Application Accepted

  Published as AU-B-2006286563

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286568-11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1

2006286535-Novel cycloalkane carboxamides as factor Xa inhibitors